New Anti-Cholesterol Pill OKd

Friday, 03 May 2013 05:14 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday.

The new combination drug will be sold under the brand name Liptruzet and will begin shipping to wholesalers next week, the company said.

Merck already sells a two-drug cholesterol fighter called Vytorin that combines Zetia, known chemically as ezetimibe, with Merck's older LDL lowering medicine Zocor. Lipitor, known chemically as atorvastatin, is considered to a more powerful statin than Zocor.

Vytorin, which had sales of $1.75 billion in 2012, is currently undergoing a long-term trial to prove that it can reduce heart attacks and strokes better than Zocor (simvastatin) alone.

While results of that study should definitively determine the value of Zetia to patients, the drug on its own rang up sales of $2.67 billion in 2012.
 
"No incremental benefit of Liptruzet on cardiovascular morbidity and mortality over and above that demonstrated for atorvastatin has been established," Merck said. The new drug will be available in four doses, combining 10 milligrams of Zetia with either 10, 20, 40 or 80mg of atorvastatin.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Once-a-Week Diabetes Drug

Tuesday, 15 Apr 2014 12:10 PM

The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 d . . .

Grass Allergy Pill a First for US Sufferers

Wednesday, 02 Apr 2014 07:05 AM

France's Stallergenes has received U.S. regulatory approval to sell the first immunotherapy pill against grass allergies . . .

New Help for Hemophilia Patients

Saturday, 29 Mar 2014 10:07 AM

The Food and Drug Administration has approved the first hemophilia B treatment designed to decrease frequency of injecti . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved